In addition, DAPK1, which is abundantly expressed in the brain, has been linked to neurological diseases associated with neuronal injury and may serve as a target for therapeutic intervention in the treatment of stroke, epilepsy, and Alzheimer’s disease. Here, DAPK1 is linked to nervous system disorder.